A New Treatment Approved for Alzheimer’s Disease: Aducanumab

Posted on July 15, 2021

Silver Comet Village - Brain Scan Images

Research is still ongoing to find a cure for Alzheimer’s disease and dementia, but we are making progress. A new treatment has recently been approved by the FDA that may have brought us one step closer to our goal to end Alzheimer’s disease.

Since the discovery of Alzheimer’s disease and other forms of dementia, research and care has come a long way. As a senior living provider in Powder Springs, Georgia, Silver Comet Village wants to share what this newly approved Alzheimer’s disease treatment could mean for the future.

The New Aducanumab Treatment

What is the Treatment?

Aducanumab, the generic form of Aduhelm™ from Biogen, is our next step to finding a cure for Alzheimer’s disease. While this new therapy is not a cure in itself, it is the first therapy of its kind.

This historic new Alzheimer’s disease treatment is revolutionary for two reasons. The first is that it is the first FDA-approved Alzheimer’s disease treatment since 2003. The second is that it is the first therapy in history to “address the underlying biology of Alzheimer’s disease (Alzheimer’s Association).”

While previous Alzheimer’s disease treatments aim to suppress the symptoms of the disease, aducanumab works to slow down the progression of Alzheimer’s, attacking and reducing the number of amyloid plaques that build up in the brain. By doing so, the aducanumab therapy could mean more time for individuals to maintain their independence, interact with friends and family members, and hold onto their memories for a longer period of time.

Who Should Receive Aducanumab?

The FDA is not requiring any specific diagnostic testing; however, the label states that aducanumab is indicated for the treatment of Alzheimer’s disease based on the presence of amyloid-beta plaques, those of which are required for an Alzheimer’s disease diagnosis. 

Additionally, this therapy is the first to “demonstrate that removing amyloid from the brain may delay cognitive and functional decline in people living with early Alzheimer’s (Alzheimer’s Association).” What this means is that aducanumab is recommended for those living with the early stages of the disease, further proving that early detection and diagnosis are essential to preventing the progression of the condition.

The Alzheimer’s Association also states that “there is no evidence that aducanumab can restore lost memories or cognitive function.” Still, the sooner an individual receives the treatment, the more beneficial it will likely be.

One issue with this is that individuals may not realize that they have it during the early stages of Alzheimer’s disease. If they are experiencing minor lapses in memory, they may chalk it up to it being part of the aging process. Even if they do understand that they are developing this condition, they may refuse to seek medical advice because they do not believe that they need help yet.

Whatever the case may be, it is essential to receive an early diagnosis and start treatment as soon as possible in order to reap as many of the benefits as possible from the therapy and prevent the progression of the disease.DISCOVER ACTIVITIES TO PROMOTE BRAIN HEALTH

How and Where is Aducanumab Administered?

“Aducanumab is administered intravenously (IV) via a 45- to 60-minute infusion every four weeks (Alzheimer’s Association).” This infusion can be administrated in hospitals, infusion therapy centers, or even at an individual’s home by a specialized nurse.

Because the FDA has recently approved this therapy, nationwide distribution and implementation will take some time. However, if you or a loved one is experiencing memory changes or has recently been diagnosed with Alzheimer’s disease, speak to your physician about aducanumab as a potential treatment option.

“When considering any treatment, including aducanumab, it is [also] important to have a conversation with your health care provider to ensure you are a candidate for the treatment. This includes taking into account other health conditions, medications or supplements (Alzheimer’s Association).”

Silver Comet Village recognizes that life is a journey, and it is our passion to support the quest for wellness, joy, and fulfillment in your or your loved one’s life every day. Our senior living services in Powder Springs, Georgia, are designed to encourage independence and provide support in the areas your loved one needs. 

To learn more about what our village has to offer, we invite you to contact a member of our team or visit our website.